DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Murray KF, Balistreri W, Bansal S. et al.
Ledipasvir/sofosbuvir +/- ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infection.
Journal of hepatology 2017;
66: S57-S58
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.